INTERACTIONS BETWEEN LEVODOPA AND OTHER DRUGS - SIGNIFICANCE IN TREATMENT OF PARKINSONS-DISEASE

被引:14
|
作者
BIANCHINE, JR [1 ]
SUNYAPRIDAKUL, L [1 ]
机构
[1] TEXAS TECH UNIV, SCH MED, DEPT PHARMACOL & THERAPEUTICS, POB 4569, LUBBOCK, TX 79409 USA
关键词
D O I
10.2165/00003495-197306050-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:364 / 388
页数:25
相关论文
共 50 条
  • [21] INCREASED RATIO OF CARBIDOPA TO LEVODOPA IN TREATMENT OF PARKINSONS-DISEASE
    TOURTELLOTTE, WW
    SYNDULKO, K
    POTVIN, AR
    HIRSCH, SB
    POTVIN, JH
    ARCHIVES OF NEUROLOGY, 1980, 37 (11) : 723 - 726
  • [22] EARLY TREATMENT WITH A COMBINATION OF BROMOCRIPTINE AND LEVODOPA COMPARED WITH LEVODOPA MONOTHERAPY IN THE TREATMENT OF PARKINSONS-DISEASE
    OLSSON, JE
    RASCOL, A
    KORTEN, JJ
    DUPONT, E
    GAUTHIER, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (05): : 1002 - 1014
  • [23] DRUGS FOR PARKINSONS-DISEASE
    CAIRD, FI
    WILLIAMSON, J
    LANCET, 1978, 1 (8071): : 986 - 986
  • [24] BROMOCRIPTINE COMBINED WITH LEVODOPA IN PARKINSONS-DISEASE
    GAUTHIER, G
    DASILVA, AM
    EUROPEAN NEUROLOGY, 1982, 21 (04) : 217 - 226
  • [25] PIGMENTATION IN PARKINSONS-DISEASE TREATED WITH LEVODOPA
    GRAINGER, KM
    LANCET, 1973, 1 (7794): : 97 - 98
  • [26] LEVODOPA THERAPY FEATURES IN PARKINSONS-DISEASE
    POLLAK, P
    GAZETTE MEDICALE, 1985, 92 (37): : 83 - 86
  • [27] DOES LEVODOPA AGGRAVATE PARKINSONS-DISEASE
    BLIN, J
    BONNET, AM
    AGID, Y
    NEUROLOGY, 1988, 38 (09) : 1410 - 1416
  • [28] DRUGS FOR PARKINSONS-DISEASE
    不详
    LANCET, 1978, 1 (8067): : 754 - 755
  • [29] BROMOCRIPTINE IN LIEU OF LEVODOPA FOR PARKINSONS-DISEASE
    WODAK, J
    STARK, R
    GILLIGAN, B
    MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 : 28 - 31
  • [30] PROGRESSION OF PARKINSONS-DISEASE WITHOUT LEVODOPA
    GOETZ, CG
    TANNER, CM
    SHANNON, KM
    NEUROLOGY, 1987, 37 (04) : 695 - 698